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Summary.-Sera from Balb/c mice bearing Moloney leukaemia block complement
dependent antibody mediated cytotoxicity of an antiserum prepared in rats against
syngeneic Moloney virus induced lymphomata when either spleen cells from mice
bearing Moloney leukaemia (M) or an in vitro line of Moloney virus transformed cells
(MSC) are used as targets. This antiserum has been shown to recognize p30, the
major internal virion protein, as a cytotoxic target on these cells. Viral particles
were identified by electron microscopic examination of pelleted material obtained
from leukaemic sera after high speed centrifugation. However, removal of virus did
not affect the capacity of the leukaemic sera to absorb cytotoxicity of rat ILR-3 for
MSC targets, and only depressed somewhat its ability to absorb activity of the same
antisera against M targets. Virus-free leukaemic sera also blocks complement
dependent antibody mediated cytotoxicity of an antiserum prepared in goats against
the gs3 determinant of p30. This indicates that the material in leukaemic sera
responsible for the in vitro block of antibody mediated cytotoxicity was p30. A lesser
degree of block was observed with sera obtained from normal Balb/c mice, but the
nature of material responsible is as yet undefined.
THE TUMOUR associated surface anti-
gens (TASA) of the cell surface, induced
by oncogenic RNA viruses (oncorna-
viruses), have been detected also in the
serum of tumour bearing animals (Stuck,
Old and Boyse, 1964; Aoki et al., 1972).
In the serum ofmice with tumours induced
by the Gross strain of mouse leukaemia
virus (MLV-G), both type and group
specific antigens, corresponding to the
separate specificities of the Gross cell
surface antigen (GCSA), have been identi-
fied in serum (Aoki et al., 1972). The
intraviral group specific antigen, p30, has
been detected by serology and by inhibi-
tion of in vitro cell mediated cytotoxicity,
on the cell surface and in the serum ofrats
carrying Gross lymphomata (Knight,
Mitchison and Shellam, 1975).
Serum from animals with tumours
induced by oncornaviruses contains block-
ing factors which inhibit antibody and cell
mediated immunity in vitro (Knight et
al., 1975; Hellstrom and Hellstrom, 1969;
Gorczynski and Knight, 1975). In the rat
Gross lymphoma system, the question of
whether p30 blocks as free antigen or as
antigen-antibody coinplex has not been
resolved (Knight et al., 1975). In the
serum of mice with tumours induced by
Moloney murine sarcoma virus, only
complexes of antibody with a small
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mnolecular weight component, presumably
antigen, are inhibitory (Sjogren et al.,
1971; Gorczynski et al., 1975).
In a previous paper we demonstrated
that antigenic determinants of the most
abundant internal virion protein of the C
type RNA viruses, p30, are present on the
surface of spleen cells from mice bearing
Moloney leukaemia and on an in vitro cell
line derived from a Moloney sarcoma virus
(MSV-M) induced tumour (MSC) (Epstein
and Knight, 1975). Complement depen-
dent antibody mediated cytotoxicity was
Lused as the technique for detection of the
antigenic determinants of p30, using an
antiserum (ILR-3) prepared in rats against
a syngeneic Moloney virus (MLV-M)-
induced lymphoma and a goat antiserum
(goat anti-gs3) prepared against disrupted
feline leukaemia virus (FeLV). Both
antisera were cytotoxic for Moloney leu-
kaemia spleen cell (M) and MSC targets
and in each instance the cytotoxicity was
at least partially absorbed by purified
preparations of p30.
The purpose of the present study was
to determine if antigenic determinants of
the p30 molecule could be detected in sera
ofBalb/c mice bearing Moloney leukaemia
by using such sera to block the antibody
mediated cytotoxic reactions agaiinst both
types of target cells.
MATERIALS AND METHODS
Details concerning the source and mainte-
nance of Balb/c mice, passage of Moloney
leukaemia in vivo and MSC cells in vitro,
preparation of antisera and rabbit comple-
ment and performance of the 5'Cr release
antibody mediated cytotoxicity test are
described in the previous paper (Epstein and
Knight, 1975). Both antisera employed, i.e.
the Rat ILR-3 and the goat anti-gs3 recognize
antigenic determinants of the p30 molecule
on both M and MSC cells.
Mouse sera.-Blood was obtained by
cardiac puncture from Balb/c mice at various
time intervals from 3 to 12 days after they had
received an intraperitoneal injection of
1 x 107 viable spleen cells from syngeneic
donors known to have MoloIey leukaemia.
Blood was pooled fromn 3-6 aninmals of a
given group at each time point, allowred to clot
at room temperature, and centrifuged for
15 min at 2000 g. The serum was withdraw,n
and frozen in 100 yl aliquots at -20°C for
future use.
Parallel samples of serumn were also
obtained from age and sex matched un-
injected, non-leukaemic mice, which were
housed in separate cages but in the same
room as the leukaemic mice. Such samples
-were taken 7 or 12 days after the mice
received leukaemic cells. On numerous
occasions serumsamplesfromeither leukaemic
or control mice were subjected to further
centrifugation at 105,000 g (MSE superspeed
65, MSE Ltd, Crawley, Sussex) for 1 h at
5°C to sediment any viral particles.
Electron microscopy.-Pellets obtained
from serum spun at 105,000 g for 1 h were
examined with an AEI EM6B electron micro-
scope for the presence of viral particles. The
pellets were fixed in a solution of osmium
tetroxide and glutaraldehyde buffered by
0-2 mol/l Na cacodylate buffer (pH 7.4) using
a modification of the technique of Hirsch and
Fedorko (1968). Silver Araldite sections were
prepared and double stained with uranyl
acetate and Reynold's lead citrate.
Absorption of antisera with mouse sera.-
Various volumes of mouse serum (5-50 ,ul)
were combined with either neat Rat ILR-3 or
goat anti-gs3 and sufficient medium (Dul-
becco's modification of Eagle's medium with
glutamine (E-4-G1) supplemented with 10%
normal rat or goat serum) to bring the anti-
serum to the dilution required in a final
volume of 0-1 ml. The xenogeneic serum
mixtures were kept at room temperature for
30 min and then employed in the 5ICr
release assay.
Antibody cytotoxicity assay.-Either M
leukaemia spleen cells (5 x 105 viable) or
MSC cells (1 x 105 viable) were used as
targets in the assay and were labelled with
5'Cr as described previously (Epstein and
Knight, 1975). For each assay total 5tCr
label, spontaneous 51Cr release and maximum
release by Brij detergent (polyoxyethylene
lauryl ether, Pierce Chemical Co., U.S.A.)
were determined. In addition, control tubes
were prepared to determine the effect of
rabbit complement (1: 3), E-4-GI with 10%
normal rat orgoat serum, normalorleukaemic
mouse serum, and combinations of these on
5'Cr release. The formulae for calculating 00
specific cytotoxicity and 0% block are ex-
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plained in detail in the previous paper
(Epstein and Knight, 1975). A percentage
block ofgreater than 100% indicates that the
cytotoxic antibody and the material used to
albsorb it cause less 51Cr release from the
target cells in the presence of complement
than does the complement control, but never
less than the spontaneous release of 5'Cr
from the target cells.
Determination of spleen weights.-Groups
of 4 Balb/c mice were killed at various
time inteirvals after they had received an
intraperitoneal injection of 1 X 107 viable
spleen cells from syngeneic mice bearing
Moloney leukaemia. In addition, age and sex
matched control mice were killed. Spleens
were excised and weighed in vials containing
25 ml of 10% formaldehyde.
RESULTS
Development of leukaemia
The increase in spleen weight of
Balb/c mice at various time intervals after
injection with spleen cells from syngeneic
leukaemic animals is shown in Fig. 1.
Spleen weights of control, age and sex
matched non-leukaemic animals are also
shown. It is apparent from the (lata that
splenic enlargement is a hallmark of the
leukaemic process and that maximum rate
of splenic enlargement occuirs within 8
days after animals receive leuikaemic cells.
After this time the rate of splenic enlarge-
ment decreases.
Ability of leukaemic sera to block in vitro
antibody mediated cytotoxicity
Three experiments were performed to
determine if sera obtained from leukaemic
mice could block complement dependent
antibody mediated cytotoxicity of rat
ILR-3 for M leukaemic target cells. In
the first 2 of these experiments sera were
obtained from one group of animals but
tested in cytotoxic assays on target cells
obtained from 2 other separate grotups of
animals. In the second and third experi-
ments, sera were obtained from 2 distinct
groups of animals, each tested against
target cells obtained from only one group
of animals. The mean 00 specific cyto-
toxicity of aii unabsorbed 1120 (liluition of
Rat ILR-3 for M targets used in these
experiments was 5400.
The results, depicted in Fig. 2, indicate
that with increasing duration oftime after
the mice received leukaemic cells, their
sera contain increasing amounts of
material capable ofabsorbingthecytotoxi&
activity of a 1/20 dilution of rat ILR-3 for
MI target cells in vitro. The results
depicted are for 20 1, of leukaemic sera.
A lesser degree of block was observed in
parallel experiments in which 10ld was
used, and a greater degree in which 501,
was used.
When these same sera were centrifuged
at 105,000 g to remove any intact viral
particles and studied for their ability to
block the cytotoxic activity of a 1/20
dilution of Rat ILR-3 for AM target cells,
the data observed in Fig. 3 were obtained.
It is apparent from all 3 experiments
that leukaemic serum is capable of
blocking the cytotoxic reaction even after
the removal of intact viral particles, and
that the maximum response is observed
with 7-day serum.
Given the fact that the same batches of
leukaemic and control sera were used in'
experiments 1 and 2, several conclusions
may be made from the data depicted in
Fig. 2 and 3. There is excellent agreement
between assays performed 2 weeks apart
using the same leukaemic serum. For
example, in Fig. 3, Day 7, spun serum
produced 73% block in experiment 1 and
710% block in experiment 2; Day 12 spun
serum produced 44% block in experiment
1 and 400% block in experiment 2. Similar
results were obtained with unspun serum,
as seen in Fig. 2. Day 7 serum produced
83% block in experiment 1 and 86%
block in experiment 2. The same was not
true for the control serum. For example,
as shown in Fig. 2, unspun control serum
produced 310 block in experiment 1 but
2 weeks later no block was observed.
Similarly, with spun serum 37% block was
observed in experiment 1 and only 500 in
experiment 2. This suggests that the
inhibitor in normal mouse serum is less
stable than that in leukaemic serum.
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FIG. 1. Spleen weights ofBalb/c mice at 4, 8 and 14 days after receiving leukaemic cells (0*). Spleen
weights of control non-injectedl mice (0). Each point represents the mean weight ± s.e. mean
from 4 animals.
Since, however, after high speed cen-
trifugation there was no diminution in the
ability of control serum to block, the
presence ofviral particles in normal serum
is unlikely.
Leukaemic serum does contain a com-
ponent sedimentatable at 105,000 g that is
capable ofblocking the cytotoxic reaction,
as high speed centrifugation resulted in a
diminution in the ability of leukaemic
sera to block. For example, in experiment
1 a diminution in block of 10% with Day 7
serum, 46% with Day 8 serum and 89%
with Day 12 serum was observed after
high speed centrifugation.
Electron microscopic examination of
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Fi. 2.-The ability of unspun leukaemic sera (taken at various time points in the clevelopment of the
leukaemia) to block complement dependent antibody mediated cytotoxicity of Rat ILR-3 against
12 day leukaemic spleen cell targets. Results plotted are those using 20 ul of sera. Control
values, obtained from age and sex matched animals, are plotted at time 0. Experiments 1 and 2
were performed 2 weeks apart with the same sera, but with targets cells from 2 separate groups of
animals, 12 days after they each received leukaemic cells. The serum obtained at Day 8 was not
tested in experiment 2. Experiments 2 and 3 were performed on the same day but with sera
obtained from separate groups of animals. As in experiment 1, Day 12 targets cells were used.
The formula for calculating %0 block is described in Materials and Methods in the previous paper
(Epstein and Knight, 1975).
the sedimented material confirmed the
presence of viral particles in leukaemic
sera in increasing amounts with time.
For these studies the same sera employed
in experiments 1 and 2 were examined.
Viral particles were found in the pellets of
serum from Day 8 and Day 12, with more
present at Day 12 than Day 8. No viral
particles were detected in pellets prepared
from control serum or from Day 7 leu-
kaemic serum. This direct evidence
strikingly confirms the serological data
discussed above.
Several experiments were then per-
formed to determine if spun leukaemic sera
could also block the complement depen-
dent cytotoxicity of Rat ILR-3 for MSC
target cells just as it did for M targets.
Two representative experiments are de-
picted in Fig. 4. For these experiments
sera obtained from 2 separate groups of
animals were tested against the same
target cells. The mean % specific cyto-
toxicity of a 1/10 dilutionof Rat ILR-3 for
the MSC targets was 32/o. The data
indicate that increasing amotnts of spun
leukaemic serum results in increasing
block of cytotoxicity of Rat ILR-3 for
MSC targets. Both control sera blocked
the reaction to about the same extent as
Day 3 or Day 4 leukaemic serum. How-
ever, leukaemic serum taken after 4 days
uniformly blocked the reaction consider-
ably more than control serum.
In the experiments depicted in Fig. 3
in which M targets were employed there
was a decline in the ability of 20 ,l of 12
day leukaemic serum in comparison with
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Fie-;. 3. The ability of spuIn leukaemic isera to block comp)lement depii(lenet antibody me(liate(l
cytotoxicity of Rat ILR-3 against 12 (lay leukaemic spleen targets. Results plotted are those
using 20 Id of sera. Control values obtained from age and sex matched animals are plotted at
time 0. The souirce of sera for these experiments was the same as indicated in the legendl for Fig. 2.
7 or 8 day serumn to block the cytotoxic
reaction of Rat ILR-3. In Fig. 4, in which
MSC targets were employed, this decline
(at the 20 ,u dose) is not present in one of
the experiments and amounts to only 100%
in the other.
A comparison was then made between
the difference in the ability of spun and
unspun leukaemic sera to block in experi-
ments employing either M or MSC targets.
For these experiments, separate batches
of sera were employed and the data are
illustrated in Fig. 5. Assuming th2Jt (as
we had demonstrated above) in each
instance viral particles were present after
Day 7 and that they were successfully
removed by high speed centrifugation, it is
apparent that such removal of virus had
little effect on the ability ofleukaemic sera
to block the cytotoxicity of Rat lLR-3 for
MSC targets. In contrast, considerable
difference was noted between unspun and
spunl1 sera lIse(l to absorb ouit cytotoxicity
against M targets, especially when Day 12
serum was employed. These experiments
suggest therefore that intact virus played
a relatively minor role in the absorption
of cytotoxic activity of Rat ILR-3 against
MSC targets and a somewhat more
important role in the absorption of cyto-
toxicity of the same antisera against M
targets. As a corollary of this, intact
Moloney virus or viral envelope antigen
(YEA) should be present and accessible to
Rat ILR-3 on M targets. That such isthe
case was shown previously (Epstein and
Knight, 1975), when an anti-serum pre-
pared in rats against formalinized MSV-M,
which is virus neutralizing, was found to
be cytotoxic for M targets. Of further
interest is the fact that in one experiment
as little as 20 ,ll of unspun, virus contain-
ing Day 8 leukaemic serumresultedin 810
block of this reaction. This suggests that
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Fie(ff. 4. The ability of spuni leukaemic sera to block complement (lependent anitibo(ly mediate(l
cytotoxicity of Rat, ILR-3 against MSC targets. The sera employed in these studies were obtained
from 2 separate grouips of mice bearing Moloney leukaemia. Control sera were obtained from age
andl sex matched animals. The MSC targets were used 3 (lays after passage in vitro.
VIEA determinants may be present in
unspun leukaemic serum and on the
surface of M targets. We have not
studied this antiserum with MSC targets.
Since our previous study (Epstein and
Knight, 1975) had identified antigenic
determinants of the p30 molecule on the
surface of both M and MSC targets, we
performed 2 experiments to determine if
p30 could be the material in spun, virus-
free leukaemic serum that absorbed cyto-
toxic ILR-3 antibodies. Samples of spun
leukaemic sera (10, 20 or 50 ,tl) obtained
at 7, 8 and 12 days were used to absorb an
antiserum prepared in goats against dis-
rupted FeLV and which reacts with the
interspecies gs3 determinant of p30. Con-
trol spun serum was also tested. The
ability of the leukaemic sera to block the
cytotoxicity of the goat-anti-gs3 against
12 day M targets was then studied, and the
data from a representative experiment are
shown in Fig. 6. Maximum block was
achieved with 7 day leukaemic serum, and
slightly less block with Day 8 serum.
Day 12 and control sera blocked the
reaction to the same extent. These data
are consistent with those depicted in
Fig. 3 where a decline in bloc1ing ability
ofDay 12 spun serum was notedinthe Rat
ILR-3-M target system and suggests the
presence of p30 in leukaemic serum, and
lesser quantities of it, or some other
material with cross reacting antigenic
determinants, in serum fromnormalBalb/c
mice.
DISCUSSION
The present study demonstrates that
sera obtained from mice bearing Moloney
leukaemia block the in vitro complement
dependent, antibody mediated cytotoxi-
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FieJ. 5. Difference between the ability of virus containing (tunispun) an(d virus-free (spuin) leukaernic
sera toblockantibody mediated cytotoxicity of at ILR-3 for l\ orMSC targets. (*) Experiments
in which M spleen cells were targets. (*) Experimenits in x%hich MISC cells were tariget.s.
city of aRat anti-syngeneic Aloloney virus
induced lymphoma (Rat ILR-3) for 2
types of target cells, Moloney leukaemic
spleen cells (M) and an in vitro line of
Moloney virus transformed sarcoma cells
(MSC). Our previous study (Epstein and
Knight, 1975) indicated that this anti-
serum could detect antigenic determinants
of p30, the most abundant internal virion
protein of the C type RNA viruses on the
surface of both of these targets. We
found that as little as 04 18 ,/g of a purified
preparation of p30 obtained by isoelectric
focusing could block 4300 of the cyto-
toxicity of this antiserum for MSC targets
and 10000 of its cytotoxicity for M
targets. Thus, the fact that leukaemic
sera could also block thase cytotoxic
reactions suggested that the antigenic
determinants of p30 were components of
leukaemic serum, as well as being present
on the surface of the target cells.
Additional supportive evidence for the
presence of p30 in leukaemic sera comes
from our observation hereinthatleukaemic
sera can also absorb cytotoxic antibody
recognizing the interspecies group specific
determinant (gs3) of the p30 molecule.
The ability to block this reaction was
maximum 7 days after the mice received
520
I I.. IP30 IN MOLONEY LEUKAEMIC SERA
WAin - 3uu
200
Ca
X 100
Day 7
Day S
tDay It
Control
I I I I
0 20 40
SERUM VOLUME(AiI)
FIG. 6.-The ability of spun leukaemic sera
to block complement dependent antibody
mediated cytotoxicity of an antiserum pre-
pared in goats against the interspecies (gS3)
determinant of p30.
leukaemic cells and then seemed to decline
by 12 days. The decline in levels or
accessibility ofp30 seeninleukaemic serum
at 12 days parallels that which we pre-
viously observed for the presence or
accessibility of antigenic determinants of
p30 on the surface of spleen cells taken
from Moloney leukaemic animals (Epstein
and Knight, 1975). The ability of a given
number of such spleen cells to absorb the
cytotoxic antibody activity of the goat
anti-gs3 was maximum at Day 8, and
declined by Day 12.
In the present study we also observed
that leukaemic sera from which viral
particles were removed by centrifugation
could also block the cytotoxic reaction of
Rat ILR-3 and goat anti-gs3. That virus
was present in the sera of the animals
bearing leukaemia was established by
observing viral particles by electron micro-
scopy in the pelleted material ofleukaemic
sera subjected to high speed centrifuga-
tion. Virus was first detected in sera
from animals who received leukaemic cells
8 days previously, and by 12 days after
passage of the leukaemia viral particles
had markedly increased. Thus, the pre-
sence of the group specific internal virion
protein, p30, in Moloney leukaemic sera
and on leukaemic cells reachesamaximum
level by Day 7-8 and declines, and
thereafter intact virus particles are detect-
able and continue to increase in number.
These time course relationships are con-
sistent with assembly and production of
new virus at the cell surface and release
into the circulation. It is also of interest
that the maximum levels ofp30 are seen in
the sera and on leukaemic cells at a time
when maximum rate of growth of the
leukaemia occurs.
Elimination of viral particles from
leukaemic sera by centrifugation had no
depressive effect on the ability of the sera
to absorb the cytotoxic activity of Rat
ILR-3 against MSC targets. This suggests
that the internal virion protein, p30,
present in both spun and unspun pre-
parations was the major substance respon-
sible for block in that system. This is
compatible with our previous observations
that for a given number of MSC targets
the amount or accessibility of p30 for
cytotoxic reactions was greater than that
observed for M targets (Epstein and
Knight, 1975). We showed that a given
amount of purified p30 blocked the
reaction of Rat ILR-3 against M targets
more completely than that against MSC
targets, where presumably there was more
antigen to block.
In contrast, elimination- of viral par-
ticles from leukaemic sera did have a
depressive effect on the ability ofthe virus
free sera to absorb the cytotoxicity ofRat
ILR-3 for M targets. Virus free sera were
still capable of blocking (Fig. 3) but to a
lesser degree than with intact virus. This
occurred for 2 reasons. First there was a
depression in the level of p30 in Day 12
serum as compared with Day 7 or 8, and
small changes in p30 levels would have
significant effects on blocking ability in a
system utilizing target cells such as the M
cells which had relatively less p30 present
or accessible then MSC cells. Second,
antigens associated with the intact virion,
possibly VEA, have been shown to be
involved in the reaction ofRat ILR-3 with
M cells, since intact MSV-M as well as
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purified VEA preparations can absorb
some of the cytotoxic activity.
The discovery and identification ofp30
as a component of leukaemic serum are
compatible with several previous observa-
tions in the literature. First, Stuck et al.
(1964) described the presence of soluble
antigen in the plasma of mice with
Rauscher virus inducedleukaemia, distinct
from infective virus particles, and with the
same specificity as the cellular antigens of
this leukaemia. Similar material was
found in the plasma of mice with leukae-
mia induced by Moloney or Friend virus.
Geering, Old and Boyse (1966) have also
described a group specific soluble antigen
demonstrable by immuno-precipitation,
which was shared by both Gross and
Friend, Moloney or Rauscher induced
leukaemias. Our results are thus com-
patible with their observations and in
agreement with Ferrer's recent suggestion
that p30 is the molecular equivalent of
GCSA (b), a group specific antigen on the
surface of Gross virus induced lymphoma
cells. We have extended these observa-
tions to identify p30 both on the surface
of Moloney virus infected or transformed
cells and in the sera of mice bearing
Moloney leukaemia.
The nature of the material which we
found in normal Balblc sera and which
partially blocks the cytotoxic reaction of
Rat ILR-3 and the goat anti-gs3 is still
uncertain. Moloney found no evidence of
horizontal transmission of Moloney leu-
kaemia to control mice housed even in the
same cage (Moloney, 1962) and the control
mice used in the present study were kept
even further away in separate cages.
Further, we found no electron microscopic
evidence of virus in pelleted material
obtained from normal serum subjected to
high speed centrifugation, thus ruling out
the possibility of active viral infection in
the control mice. In addition, thestability
to storage at -20°C of the material in
control sera was less than that of the p30
in leukaemic serum. It is of interest that
Abelev and Elgort (1970), using an indi-
rect immunoautoradiographic technique,
found trace quantities of group specific
internal virion antigens of murine leu-
kaemia viruses in the sera of normal mice
of one strain of low leukaemia incidence
(i.e. C57B1/6), but not in the serum of
Balblc mice, also considered to be a low
leukaemia incidence strain. Further char-
acterization of the material found in
normal Balb/c sera in the present study
would therefore be of interest.
Recently, Shellam and Knight (1974)
demonstrated that serum fromratsbearing
progressively growing Gross virus induced
syngeneic lymphomata will block T lym-
phocyte cytotoxicity for tumour targets.
p30 is also implicated in this system, as
these same authors have shown that
purified preparations of the protein can
partially block T cell cytotoxicity and
completely block syngeneic antibody
mediated cytotoxicity (Knight et al.,
1975).
Thus, in this and in a previous paper
(Epstein and Knight, 1975) we have
defined a system in which a group specific
internal virion protein is associated with
and serves as a cytotoxic target on the
surface of Moloney virus infected or
transformed cells, and is present in the
sera of mice bearing Moloney leukaemia.
Whether p30 serves to abrogate host
defence mechanisms in vivo as well as in
vitro and in what form it exists in the sera,
i.e. as free antigenic determinants or
antigen-antibody complexes remains to be
established.
The authors wish to thank Mr Roy
Mahoney for preparing the electron micro-
graphs.
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